Exela Pharma Sciences, LLC

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Exela Pharma Sciences, LLC
Quantité totale PI 24
Rang # Quantité totale PI 63 171
Note d'activité PI 2,4/5.0    27
Rang # Activité PI 28 947

Brevets

Marques

24 0
0 0
0 0
0
 
Dernier brevet 2026 - Stable, highly pure l-cysteine c...
Premier brevet 2014 - Ganciclovir compositions and rel...

Derniers inventions, produits et services

2024 Invention Stable, highly pure l-cysteine compositions for injection and methods of use. 2 that is less than...
Invention Ganciclovir compositions and related methods. Gancyclovir formulations that are ready-to-use, su...
2020 Invention Ganciclovir compositions and related methods. Gancyclovir formulations that are ready-to-use, sub...